BioRestorative Therapies announced that two directors left and David Jenkins is now a director.

Nov 12, 2026, 5:05 PM ETNew bossRead the original at SEC EDGAR

Neutral

BioRestorative reported 2 director resignations and appointed David Jenkins to fill one vacancy. The filing cites no disputes or business changes, and Jenkins's CAD $2,000 monthly fee adds a cost, so the board news does not clearly change the company's outlook.

BRTX · BioRestorative Therapies, Inc.

AI read · Neutral

The AI's read

The departures were not linked to disagreements over company operations, policies, or practices. Jenkins is described as independent and as an audit committee financial expert, which adds relevant oversight experience. The filing also sets a CAD $2,000 monthly fee, but reports no change to the company's business, so the board news does not clearly alter its outlook.

Get alerts for BRTX

Follow BioRestorative Therapies, Inc. (BRTX) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for BRTX

Free on the App Store and Google Play, or on the web.